Recent Posts
- Hemanext Inc. Announces a Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System
- Hemanext Announces Founder Martin Cannon’s Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth
- Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
- Hemanext annonce un partenariat avec The Aplastic Anemia & MDS International Foundation (AAMDSIF)
- Hemanext ONE devient le premier système de traitement et de stockage du sang à recevoir un sceau de conformité aux normes de l’AABB